Doctor profile · Federal record

Dr. Alicia Wollermann, M.D.

Rheumatology Physician (CMS: Rheumatology) · Voorhees, NJ

  • NPI 1629199591
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 23 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2301 E. Evesham Road, Bldg 800, Suite 115
Voorhees, NJ 08043
(856) 424-5005
fax (856) 424-4716

Credentials & registration

NPPES · NUCC
NPI registered
April 2007 — 19 yrs on file
Profile last updated
August 29, 2019
Year of graduation
2003 — 23 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
New Jersey #25MA08032500

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1629199591. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
106,101
Distinct HCPCS
10
Medicare allowed
$1,213,639
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 49,760 19 $6
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 23,800 14 $5
J1602 Injection, golimumab, 1 mg, for intravenous use 16,536 34 $12
J0897 Injection, denosumab, 1 mg 6,840 86 $23
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 3,225 17 $42
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2,680 16 $33
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 986 125 $1
99214 Established patient office or other outpatient visit, 30-39 minutes 642 378 $137
96413 Administration of chemotherapy into vein, 1 hour or less 291 94 $145
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 253 102 $82

In context: peer comparison

Among 10 peers in Voorhees Rheumatology Physician, average services per provider: 3,572. This provider delivers 30× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$142
Transactions
5
Manufacturers
3
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, INC. 1 $79.99
Abbvie INC. 3 $47.38
E.R. Squibb & Sons, L.L.C. 1 $15.00

By nature of payment

Education
$80
Food and Beverage
$62

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,668
Patients
585
Total drug cost
$409,491
Drug Type Claims Patients Total cost
Prednisone Generic 418 152 $3,883
Duloxetine Hcl Generic 246 101 $9,686
Methotrexate (Methotrexate Sodium) Brand 229 74 $8,911
Tramadol Hcl Generic 174 48 $729
Gabapentin Generic 140 41 $1,839
Hydroxychloroquine Sulfate Generic 118 41 $7,333
Humira(Cf) Pen (Adalimumab) Brand 45 0 $369,295
Meloxicam Generic 43 18 $203
Folic Acid Generic 42 13 $114
Methylprednisolone Generic 40 32 $618

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Alicia Wollermann's medical specialty?
Dr. Alicia Wollermann practices Rheumatology Physician in Voorhees, NJ.
Where does Dr. Alicia Wollermann practice?
Dr. Alicia Wollermann practices at 2301 E. Evesham Road, Voorhees, NJ 08043. Office phone: 8564245005.
What is Dr. Alicia Wollermann's NPI?
Dr. Alicia Wollermann's National Provider Identifier (NPI) is 1629199591, issued by NPPES.
Does Dr. Alicia Wollermann accept Medicare assignment?
Yes. Dr. Alicia Wollermann accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Alicia Wollermann commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.